Home Capabilities Manufacture
Delivering world-class pharmaceutical manufacturing through advanced technologies, rigorous quality systems, and continuous innovation to improve patient lives.
Sudair Pharma operates one of Saudi Arabia's most advanced pharmaceutical manufacturing facilities, designed to produce high-quality medicines that meet international regulatory standards. Our manufacturing ecosystem combines cutting-edge technologies, highly qualified professionals, and efficient production systems to ensure safe, reliable, and scalable pharmaceutical production.
At the heart of Sudair Pharma's operations is a specialized oncology manufacturing plant designed to produce highly technical pharmaceutical products, positioning the company as the first Saudi oncology-specialized manufacturer with its own production facility in the Kingdom. Production Area 2,826.90 m² General Storage 1,848.60 m² Cold Storage 70.30 m²
Production is organized across multiple dosage-form lines, each with its own defined capacity.
An insulin manufacturing initiative is underway, progressing in phases from secondary packaging to full compounding, filling, and formulation. Commercial activity is increasing, with full-scale manufacturing targeted for 2028.
A biosimilars and monoclonal antibodies facility is being developed, covering purification, aseptic filling, and quality control aligned with EMA, FDA, and SFDA standards. The facility targets biologics development in oncology, immunology, and chronic disease treatment.
A respiratory manufacturing facility is also planned. The facility is intended to produce dry-powder inhalers, metered-dose inhalers, soft-mist devices, and sterile nebulized solutions for chronic respiratory conditions.
Expanding insulin production capacity to support local healthcare needs.
Building capabilities for biosimilars and monoclonal antibodies to improve patient access.
Advanced manufacturing for respiratory products including MDIs and nebulized solutions.
Automated production lines that improve consistency, throughput and operator safety.
Classified cleanroom environments engineered for controlled, contamination-free production.
Sterile manufacturing capability for injectable and high-risk pharmaceutical products.
Temperature-controlled storage and distribution protecting product integrity end to end.
Freeze-drying capability for stable, long-shelf-life formulations.
Digital systems supporting traceability, process control and continuous improvement.
